A P Drugs Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 36 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2023)
- Profit -32.50%
(FY 2023)
- Ebitda -32.50%
(FY 2023)
- Net Worth
- Total Assets 5.56%
(FY 2023)
About A P Drugs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jaspal Singh and Jasneet Kaur serve as directors at the Company.
- CIN/LLPIN
U24232CH1988PTC008285
- Company No.
008285
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Apr 1988
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- LocationUt, Chandigarh
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at A P Drugs?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jasneet Kaur  | Director | 14-Oct-2014 | Current |
| Jaspal Singh | Director | 18-Apr-1988 | Current |
Financial Performance and Corporate Structure Insights of A P Drugs.
A P Drugs Pvt Ltd, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 32.5% decrease in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of A P Drugs?
In 2023, A P Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
C.J.Gelatine Products LimitedActive 44 years 2 monthsJaspal Singh and Jasneet Kaur are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at A P Drugs?
Unlock and access historical data on people associated with A P Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of A P Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped A P Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
